SAB Biotherapeutics, Inc. (SABS) EV to CFO (2021)
SAB Biotherapeutics' EV to CFO came in at 90.75 for Q4 2021, up 349.6% from the prior quarter.
Powered by 
Analysis
SAB Biotherapeutics, Inc. (SABS) EV to CFO (2021) Analysis & Trends
Peer Set
Peer Comparison
API Access
SAB Biotherapeutics, Inc. EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();